AzTrials
AzTrials

Bone LossNCT04135196

A Prospective Study of Human Bone Adaptation Using a Novel in Vivo Loading Model

A study testing voluntary forearm loading task in people with Bone Loss, run by Worcester Polytechnic Institute.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to understand how different types of mechanical forces can influence bone adaptation (and make bones stronger, potentially). Forces acting on bones cause mechanical strain. In small animals, strain magnitude and rate have been shown to stimulate bone adaptation. Read more about this study

Who is it for?
Ages 21 to 40 years, women onlyHealthy volunteers can take part
Conditions the study is for
Bone Loss
What is being tested?
voluntary forearm loading task
Could I receive a placebo?
No, everyone receives an active treatment
How many people
102 participants
Where
No sites listed yet
Study dates
14 Jan 2014to 19 Jul 2019
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 40 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Female
  • Age 21-40
  • Body Mass Index [18-29]
  • 9-14 menstrual cycles/year
  • Dual energy X-ray Absorptiometry total radius bone mineral density (BMD) T-score [-2.5-+1]
  • Free of endocrinopathies
  • No known thyroid, vitamin D, or calcium abnormalities

Who cannot join

  • Fracture to wrist <5 years ago
  • Wrist Arthritis
  • Injury to the non-dominant elbow or shoulder <5 years ago
  • Diabetes
  • Severe disabling conditions
  • Cancer <5 years ago
Show all 20Show fewer
  • Metabolic bone disease
  • Androgen, estrogen, progesterone, calcitonin, Selective Estrogen Receptor Modulators, Parathyroid hormone, gonadotropin-releasing hormone or analogs used <6 months ago
  • Corticosteroids <3 months ago
  • Bisphosphonates or fluoride <3 years ago
  • Cardiovascular/pulmonary disease
  • Uncontrolled hypertension
  • Regular Tobacco use
  • Marijuana use >1 time/week
  • Alcohol >4 drinks/day
  • Pregnancy or lactation <2 years ago
  • Plan to become pregnant or donate eggs within 1 year
  • Depot medroxyprogesterone acetate contraceptive <6 months ago
  • Current participation in upper extremity loading sports (gymnastics, tennis, softball, hockey) >2 times/month
  • Low calcium intake (avoiding dairy products without taking calcium supplement)

About this study

The purpose of this study is to understand how different types of mechanical forces can influence bone adaptation (and make bones stronger, potentially). Forces acting on bones cause mechanical strain. In small animals, strain magnitude and rate have been shown to stimulate bone adaptation. This study is designed to test the degree to which strain magnitude and rate govern bone adaptation in healthy adult women.

Read the detailed description

The study consists of three Aims:

Aim 1: compare the effect on bone structure of mechanical signals with low strain magnitude, high strain magnitude, and control groups over a 12-month prospective period.

Aim 2. Compare the effect on bone structure of mechanical signals with low strain rate, high strain rate, and control groups over a 12-month prospective period.

Aim 3: Examine the effect of withdrawing mechanical signals, by measuring bone structure during the 12 months after the intervention is withdrawn.

The intervention is a voluntary forearm compression task, consisting of leaning onto the palm of the hand to produce a target force.

The primary outcome measure is change in distal radius bone mineral content (BMC).

Conditions
Bone Loss
Being tested
voluntary forearm loading task
Keywords
bone, adaptation, mechanical stimuli, women, peak bone mass
Medical subject headings
Bone Diseases, Metabolic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • voluntary forearm loading taskOther

    voluntary task, consisting of leaning onto the palm of the hand until a target force is reached. Each loading bout consists of 100 loading cycles, which takes approximately 2 minutes to complete. The task is performed 4 times per week during the intervention period.

Study groups in NCT04135196
Study groupRoleWhat they receive
Low MagnitudeExperimentalvoluntary forearm compression by leaning onto the palm of the hand with low target strain
Receives: Other: voluntary forearm loading task
High MagnitudeExperimentalvoluntary forearm compression by leaning onto the palm of the hand with high target strain
Receives: Other: voluntary forearm loading task
Low RateExperimentalvoluntary forearm compression by leaning onto the palm of the hand with low strain rate (task performed "slowly and evenly")
Receives: Other: voluntary forearm loading task
High RateExperimentalvoluntary forearm compression by leaning onto the palm of the hand with high strain rate (task performed "as quickly as possible, with a bump")
Receives: Other: voluntary forearm loading task
ControlNo interventionobservation only

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in UD iBMC

    12-month change in ultra-distal integral bone mineral content, measured with quantitative computed tomography (QCT)

    Measured: baseline and 12 months

Secondary outcomes (13)
  1. Change in UD cBMC

    12-month change in ultra-distal cortical bone mineral content, measured with quantitative computed tomography (QCT)

    Measured: baseline and 12 months

  2. Change in UD ecBMC

    12-month change in ultra-distal endocortical bone mineral content, measured with quantitative computed tomography (QCT)

    Measured: baseline and 12 months

  3. Change in UD tBMC

    12-month change in ultra-distal trabecular bone mineral content, measured with quantitative computed tomography (QCT)

    Measured: baseline and 12 months

  4. Change in UD iBMD

    12-month change in ultra-distal integral volumetric bone mineral density, measured with quantitative computed tomography (QCT)

    Measured: baseline and 12 months

  5. Change in UD cBMD

    12-month change in ultra-distal cortical volumetric bone mineral density, measured with quantitative computed tomography (QCT)

    Measured: baseline and 12 months

  6. Change in UD ecBMD

    12-month change in ultra-distal endocortical bone mineral density, measured with quantitative computed tomography (QCT)

    Measured: baseline and 12 months

  7. Change in UD tBMD

    12-month change in ultra-distal trabecular bone mineral density, measured with quantitative computed tomography (QCT)

    Measured: baseline and 12 months

  8. Change in UD iBV

    12-month change in ultra-distal integral bone volume, measured with quantitative computed tomography (QCT)

    Measured: baseline and 12 months

  9. Change in UD cBV

    12-month change in ultra-distal cortical bone volume, measured with quantitative computed tomography (QCT)

    Measured: baseline and 12 months

  10. Change in UD ecBV

    12-month change in ultra-distal cortical bone volume, measured with quantitative computed tomography (QCT)

    Measured: baseline and 12 months

  11. Change in UD tBV

    12-month change in ultra-distal trabecular bone volume, measured with quantitative computed tomography (QCT)

    Measured: baseline and 12 months

  12. Change in Cortical Thickness

    Changes in cortical thickness at 3-month intervals, measured with high resolution peripheral quantitative computed tomography (HRpQCT)

    Measured: measurements repeated at 0, 3, 6, 9, 12, 18, and 24 months from enrollment

  13. Change in Trabecular BV/TV

    trabecular bone volume fraction expressed as the ratio of bone volume (BV) to total volume (TV) using: (BV/TV). This quantity is measured with high resolution peripheral quantitative computed tomography (HRpQCT). It is expressed as a ratio, ranging from 0 (none of the volume is occupied by bone) to 1 (all of the volume is occupied by bone).

    Measured: measurements repeated at 0, 3, 6, 9, and 12 months from enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Oct 2019
  2. Study start14 Jan 2014
  3. Primary completion29 Jun 2018
  4. Study completion19 Jul 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
102 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04135196
Sponsor's protocol ID
13-111
Status last verified
Jan 2023
First submitted
19 Jul 2019
Last updated
18 Oct 2023
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Mancuso ME, Johnson JE, Ahmed SS, Butler TA, Troy KL. Distal radius microstructure and finite element bone strain are related to site-specific mechanical loading and areal bone mineral density in premenopausal women. Bone Rep. 2018 Apr 14;8:187-194. doi: 10.1016/j.bonr.2018.04.001. eCollection 2018 Jun.

    PubMed 29963602
  • Troy KL, Mancuso ME, Johnson JE, Wu Z, Schnitzer TJ, Butler TA. Bone Adaptation in Adult Women Is Related to Loading Dose: A 12-Month Randomized Controlled Trial. J Bone Miner Res. 2020 Jul;35(7):1300-1312. doi: 10.1002/jbmr.3999. Epub 2020 Mar 30.

    PubMed 32154945

Questions about this trial

What is this clinical trial studying?

A study testing voluntary forearm loading task in people with Bone Loss, run by Worcester Polytechnic Institute.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 20 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 18 Oct 2023). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in UD iBMC (time frame: baseline and 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04135196, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Oct 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in